Nanotechnology-augmented sonodynamic therapy and associated immune-mediated effects for the treatment of pancreatic ductal adenocarcinoma. (2023)
Attributed to:
A novel tumour-responsive formulation for delivering sonodynamic treatment of prostate cancer
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s00432-022-04418-y
PubMed Identifier: 36319895
Publication URI: http://europepmc.org/abstract/MED/36319895
Type: Journal Article/Review
Volume: 149
Parent Publication: Journal of cancer research and clinical oncology
Issue: 8
ISSN: 0171-5216